PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

Drug side effects

bupropion Side Effects

The reactions most often reported to the FDA for bupropion (also sold as Wellbutrin, Zyban), with demographics, serious outcomes, and reporting trends.

Data updated 2026-05-15

41,778
FAERS reports

Data from the FDA Adverse Event Reporting System (FAERS), 2004 to 2025. A FAERS report records a temporal association, not proof of cause. See our methodology for how figures are compiled and de-duplicated.

The most commonly reported side effects of bupropion come from 41,778 reports to the FDA, broken down here by frequency, patient demographics, and serious outcomes.

This page analyzes 41,778 reports to the FDA Adverse Event Reporting System (FAERS) for bupropion (Wellbutrin): the reactions reported most often, who reported them, serious outcomes such as hospitalization, and year-over-year trends. A FAERS report does not prove the drug caused the effect, and report volume tracks how widely a drug is used, not how likely an effect is for any one person. Educational information, not medical advice.

Total Reports

41,778

Reports Mentioning Death

8,506

20.4% of reports — not proof the medicine caused the death

Hospitalizations

13,230

31.7% of reports

Top Indication

Product Used For Unknown Indication

Most Reported Adverse Reactions

COMPLETED SUICIDE
4,408
TOXICITY TO VARIOUS AGENTS
3,113
FATIGUE
2,665
NAUSEA
2,309
HEADACHE
2,218
DEPRESSION
2,175
PAIN
1,955
OVERDOSE
1,855
DRUG INTERACTION
1,690
ANXIETY
1,678
DIZZINESS
1,579
DIARRHOEA
1,522
INTENTIONAL OVERDOSE
1,352
DYSPNOEA
1,241
HYPERTENSION
1,230
SEIZURE
1,227
CONDITION AGGRAVATED
1,214
VOMITING
1,176

Who Reports Side Effects

Gender Distribution

Female 24,398 (66%)
Male 12,560 (34%)
Unknown 133

Age Distribution

0-17 1,174 (4%)
18-44 9,568 (32%)
45-64 12,586 (43%)
65-74 4,423 (15%)
75+ 1,705 (6%)

Reporting Trend by Year

2004 2025

Reactions in Death Reports

Top reactions reported in 8,506 reports where death was an outcome. These are voluntarily reported and do not establish causation.

Reaction Reports
COMPLETED SUICIDE 4,401
TOXICITY TO VARIOUS AGENTS 2,185
DEATH 1,036
CARDIO-RESPIRATORY ARREST 813
CARDIAC ARREST 689
DRUG ABUSE 586
SUSPECTED SUICIDE 583
OVERDOSE 491
RESPIRATORY ARREST 436
INTENTIONAL OVERDOSE 258
HYPOTENSION 233
FATIGUE 207
DEPRESSION 197
INTENTIONAL PRODUCT MISUSE 196
DRUG INTERACTION 186
POISONING 186
PAIN 174
HEADACHE 165

Reactions in Hospitalization Reports

Top reactions in 13,230 reports where hospitalization was an outcome.

Reaction Reports
COMPLETED SUICIDE 1,580
TOXICITY TO VARIOUS AGENTS 1,475
OVERDOSE 1,251
INTENTIONAL OVERDOSE 1,095
SEIZURE 895
DRUG INTERACTION 789
NAUSEA 713
HYPOTENSION 675
SEROTONIN SYNDROME 665
DYSPNOEA 623
FATIGUE 587
SUICIDE ATTEMPT 579
HEADACHE 576
CARDIAC ARREST 574
FALL 572
PAIN 563
ANXIETY 552
PNEUMONIA 548

Compare bupropion vs acamprosate →

What the FAERS Data Reveals About bupropion Side Effects

The FDA Adverse Event Reporting System (FAERS) contains 41,778 voluntary reports linked to bupropion and its brand equivalents (Wellbutrin, Zyban), spanning 2004 through 2025. Of those, 8,506 (20.4%) listed death as an outcome and 13,230 (31.7%) involved hospitalization. The most common indication reported alongside adverse events was Product Used For Unknown Indication.

Demographic breakdowns help contextualize who is being exposed to the drug. Of reports with known sex, 66% were female and 34% male; age distribution skews toward 45-64, with 12,586 reports in that bracket. The single most reported reaction is completed suicide with 4,408 submissions, followed by toxicity to various agents and fatigue.

How to read these numbers

FAERS is a signal-detection tool, not a scorecard. Reports are voluntary, and a single case may list multiple suspect drugs, so numbers above should not be read as incidence rates or per-patient risk. Widely prescribed drugs naturally accumulate more reports than niche therapies even when individual risk is low. These aggregates are useful for spotting patterns that merit further pharmacovigilance, not for choosing between medications. This page is for educational reference only and is not medical advice, speak with a licensed clinician about any side-effect concerns.